• leader board size
Consumer Research2020-11-05T23:41:25-08:00

Consumer Research

Silo Pharma Initiates Safety Study for PTSD Drug SPC-15

LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, has commenced a 7-day safety and toxicology study for its lead candidate, SPC-15, an intranasal treatment targeting post-traumatic stress disorder (PTSD). The study is being conducted ...

Cresco Labs Reports Q2 2025 Financial Results

CHICAGO – Cresco Labs Inc. released its Q2 2025 financial results, revealing a mix of operational stability, revenue headwinds, and a pivotal debt restructuring. The company reported revenues of $164 million, down 11% from $184 ...

MariMed Reports Q2 2025 Financial Results

NORWOOD – MariMed Inc. released its financial results for Q2 2025 ended June 30, reflecting a blend of operational growth and financial challenges. The company reported revenue of $39.6 million, a slight decline from $40.4 ...

MediaJel Partners with Smart AdServer

WALNUT CREEK, Calif. - MediaJel, the digital marketing and programmatic software platform for regulated brands, announced an exclusive partnership with Smart AdServer, an independent ad monetization platform. With a shared vision to level-set the adtech ...

Seattle Decriminalizes Most Psychedelic Drugs

SEATTLE–Seattle’s City Council approved a resolution Monday to decriminalize psychedelic substances, including the cultivation and sharing of psilocybin mushrooms, ayahuasca, ibogaine and non-peyote-derived mescaline. These traditional medicines had been banned during the failed ''War On ...

Subscribe To Our Newsletter

Go to Top